Biohaven Pharmaceutical Holding Company Ltd.

NYSE:BHVN

38.08 (USD) • At close September 13, 2024
Bedrijfsnaam Biohaven Pharmaceutical Holding Company Ltd.
Symbool BHVN
Munteenheid USD
Prijs 38.08
Beurswaarde 3,600,168,880
Dividendpercentage 0%
52-weken bereik 16.45 - 62.21
Industrie Biotechnology
Sector Healthcare
CEO Dr. Vladimir Coric M.D.
Website https://www.biohavenpharma.com

An error occurred while fetching data.

Over Biohaven Pharmaceutical Holding Company Ltd.

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III

Vergelijkbare Aandelen

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)